Re: Differences of Opinion

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Differences of Opinion

in response to

Re: Differences of Opinion

Jkj193741

posted on May 24, 2016 10:59PM

JK,

I made a few comments regarding this paper on the RVX board. Also, keep in mind that the meeting abstracts describing the top-line data and results, as well as Resverlogix news releases regarding these data have been publicly available for some time now either at the conference websites or the Resverlogix website.